Cognitive Neurology Unit Clinical Registry
Recruiting
Observational Study
Alzheimer Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 50 – 95
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Beth Israel Deaconess Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A Prospective Comparative Study Of Monoclonal Antibodies For The Treatment Of Alzheimer's Disease
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* o Patient meets clinical criteria for mild cognitive impairment or early dementia from Alzheimer's disease
* Patient has evidence of cognitive impairment on neuropsychological testing
* Patient has not progressed to the moderate stage of dementia based on neuropsychologic…
Contacts